Saxiphilin
Aquarana catesbeiana
当前结构中的状态
| Assembly | 聚集状态 | 构建体 | 突变与修饰 | 配体、离子与共同组分 | 实验方法与环境 | 结构质量 |
|---|---|---|---|---|---|---|
| 1 | 蛋白单体 单体 蛋白 × 1 PDB 声明:monomeric(1) 与蛋白拷贝数一致 | 链 A; UniProt 1–844 | 突变:F561A | A1CTG [(2Z,3aS,4R,6Z,7R,10aS)-10,10-dihydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methyl benzoate × 1 | X-RAY DIFFRACTION X-ray结晶条件:VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD, STX-C13-OBz:Saxiphilin molar ratio 1.1:1 | 分辨率 2.40 Å R-free 0.258 |
| 2 | 蛋白单体 单体 蛋白 × 1 PDB 声明:monomeric(1) 与蛋白拷贝数一致 | 链 B; UniProt 1–844 | 突变:F561A | A1CTG [(2Z,3aS,4R,6Z,7R,10aS)-10,10-dihydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methyl benzoate × 1 | X-RAY DIFFRACTION X-ray结晶条件:VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD, STX-C13-OBz:Saxiphilin molar ratio 1.1:1 | 分辨率 2.40 Å R-free 0.258 |
数据库中的同蛋白其他状态
以下每一行都是同一 UniProt 蛋白在另一个 PDB 条目中的 biological assembly, “相对当前条目”直接指出证据层面的不同;没有差异标签表示当前已读取字段一致。
| 其他 PDB | 相对当前条目 9YBD | Assembly / 聚集状态 | 构建体 | 突变与修饰 | 配体、离子与非聚合物 | 实验方法与环境 | 结构质量 |
|---|---|---|---|---|---|---|---|
| 6O0D Saxiphilin Apo structure 提交 2019-02-16 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
未记录 | 未记录非水小分子 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;277.15 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 40% 2-methyl-2,4-pentanediol (MPD)
|
分辨率 2.50 Å R-free 0.253 |
| 6O0D Saxiphilin Apo structure 提交 2019-02-16 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
未记录 | 未记录非水小分子 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;277.15 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 40% 2-methyl-2,4-pentanediol (MPD)
|
分辨率 2.50 Å R-free 0.253 |
| 6O0E Saxiphilin:STX complex, soaking 提交 2019-02-16 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
未记录 | 9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 40% 2-methyl-2,4-pentanediol (MPD). 1mM final concentration of STX was added during soaking
|
分辨率 2.50 Å R-free 0.262 |
| 6O0E Saxiphilin:STX complex, soaking 提交 2019-02-16 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
未记录 | 9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 40% 2-methyl-2,4-pentanediol (MPD). 1mM final concentration of STX was added during soaking
|
分辨率 2.50 Å R-free 0.262 |
| 6O0F Saxiphilin:STX complex, co-crystal 提交 2019-02-16 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
未记录 | 9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;277.15 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 40% 2-methyl-2,4-pentanediol (MPD). STX: Saxiphilin molar ratio 1:1.1
|
分辨率 2.12 Å R-free 0.259 |
| 6O0F Saxiphilin:STX complex, co-crystal 提交 2019-02-16 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
未记录 | 9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;277.15 K;0.1 M sodium cacodylate pH 6.5, 5% PEG 8000, and 40% 2-methyl-2,4-pentanediol (MPD). STX: Saxiphilin molar ratio 1:1.1
|
分辨率 2.12 Å R-free 0.259 |
| 8D6P Rana catesbeiana saxiphilin mutant - Y558A 提交 2022-06-06 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
突变:Y558A | 未记录非水小分子 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD
|
分辨率 2.60 Å R-free 0.264 |
| 8D6P Rana catesbeiana saxiphilin mutant - Y558A 提交 2022-06-06 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
突变:Y558A | 未记录非水小分子 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD
|
分辨率 2.60 Å R-free 0.264 |
| 8D6Q Rana catesbeiana saxiphilin mutant - Y558I 提交 2022-06-06 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
突变:Y558I | 未记录非水小分子 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 27% MPD
|
分辨率 2.70 Å R-free 0.272 |
| 8D6Q Rana catesbeiana saxiphilin mutant - Y558I 提交 2022-06-06 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
突变:Y558I | 未记录非水小分子 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 27% MPD
|
分辨率 2.70 Å R-free 0.272 |
| 8D6S Rana catesbeiana saxiphilin mutant - Y558A:STX (co-crystal) 提交 2022-06-06 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
突变:Y558A | 9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD, STX:Saxiphilin molar ratio 1.1:1
|
分辨率 2.60 Å R-free 0.262 |
| 8D6S Rana catesbeiana saxiphilin mutant - Y558A:STX (co-crystal) 提交 2022-06-06 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
突变:Y558A | 9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD, STX:Saxiphilin molar ratio 1.1:1
|
分辨率 2.60 Å R-free 0.262 |
| 8D6T Rana catesbeiana saxiphilin mutant - Y558I:STX (co-crystal) 提交 2022-06-06 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
突变:Y558I | 9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1 CAC CACODYLATE ION × 3 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 27% MPD, STX:Saxiphilin molar ratio 1.1:1
|
分辨率 2.15 Å R-free 0.234 |
| 8D6T Rana catesbeiana saxiphilin mutant - Y558I:STX (co-crystal) 提交 2022-06-06 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
突变:Y558I | 9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1 CAC CACODYLATE ION × 3 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 27% MPD, STX:Saxiphilin molar ratio 1.1:1
|
分辨率 2.15 Å R-free 0.234 |
| 8D6U Rana catesbeiana saxiphilin:F-STX (soaked) 提交 2022-06-06 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
未记录 | QDX (2P)-4-({6-[({[(3aS,4R,7R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methoxy}carbonyl)amino]hexyl}carbamoyl)-2-{[4aP,9(9a)P]-6-hydroxy-3-oxo-3H-xanthen-9-yl}benzoic acid × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;277.15 K;0.11-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD, 1 mM (final concentration) F-STX was added during soaking
|
分辨率 2.65 Å R-free 0.266 |
| 8D6U Rana catesbeiana saxiphilin:F-STX (soaked) 提交 2022-06-06 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
未记录 | QDX (2P)-4-({6-[({[(3aS,4R,7R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methoxy}carbonyl)amino]hexyl}carbamoyl)-2-{[4aP,9(9a)P]-6-hydroxy-3-oxo-3H-xanthen-9-yl}benzoic acid × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;277.15 K;0.11-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD, 1 mM (final concentration) F-STX was added during soaking
|
分辨率 2.65 Å R-free 0.266 |
| 9YAR Rana catesbeiana saxiphilin:STX-C13-OBz (co-crystal) 提交 2025-09-16 | 突变/修饰不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
未记录 | A1CTG [(2Z,3aS,4R,6Z,7R,10aS)-10,10-dihydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methyl benzoate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 27% MPD, STX-C13-OBz:Saxiphilin molar ratio 1.1:1
|
分辨率 2.40 Å R-free 0.278 |
| 9YAR Rana catesbeiana saxiphilin:STX-C13-OBz (co-crystal) 提交 2025-09-16 | 突变/修饰不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
未记录 | A1CTG [(2Z,3aS,4R,6Z,7R,10aS)-10,10-dihydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methyl benzoate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 27% MPD, STX-C13-OBz:Saxiphilin molar ratio 1.1:1
|
分辨率 2.40 Å R-free 0.278 |
| 9YAS Rana catesbeiana saxiphilin mutant - Y558A:STX-C13-OBz (co-crystal) 提交 2025-09-16 | 突变/修饰不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
突变:Y558A | A1CTG [(2Z,3aS,4R,6Z,7R,10aS)-10,10-dihydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methyl benzoate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD, STX-C13-OBz:Saxiphilin molar ratio 1.1:1
|
分辨率 2.45 Å R-free 0.284 |
| 9YAS Rana catesbeiana saxiphilin mutant - Y558A:STX-C13-OBz (co-crystal) 提交 2025-09-16 | 突变/修饰不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
突变:Y558A | A1CTG [(2Z,3aS,4R,6Z,7R,10aS)-10,10-dihydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methyl benzoate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD, STX-C13-OBz:Saxiphilin molar ratio 1.1:1
|
分辨率 2.45 Å R-free 0.284 |
| 9YAT Rana catesbeiana saxiphilin mutant - T563A 提交 2025-09-16 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
突变:T563A | 未记录非水小分子 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD
|
分辨率 2.50 Å R-free 0.246 |
| 9YAT Rana catesbeiana saxiphilin mutant - T563A 提交 2025-09-16 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
突变:T563A | 未记录非水小分子 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD
|
分辨率 2.50 Å R-free 0.246 |
| 9YAV Rana catesbeiana saxiphilin mutant - F561A 提交 2025-09-16 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
突变:F561A | 未记录非水小分子 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD
|
分辨率 2.23 Å R-free 0.244 |
| 9YAV Rana catesbeiana saxiphilin mutant - F561A 提交 2025-09-16 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
突变:F561A | 未记录非水小分子 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD
|
分辨率 2.23 Å R-free 0.244 |
| 9YBE Rana catesbeiana saxiphilin mutant - F561A:STX (co-crystal) 提交 2025-09-17 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
突变:F561A | 9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD, STX:Saxiphilin molar ratio 1.1:1
|
分辨率 2.35 Å R-free 0.274 |
| 9YBE Rana catesbeiana saxiphilin mutant - F561A:STX (co-crystal) 提交 2025-09-17 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
突变:F561A | 9SL [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,9,10-tetrahydro-3H,8H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD, STX:Saxiphilin molar ratio 1.1:1
|
分辨率 2.35 Å R-free 0.274 |
| 9YBF Rana catesbeiana saxiphilin mutant - T563A:STX-C13-OBz (co-crystal) 提交 2025-09-17 | 突变/修饰不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
1–844(844 aa)
|
突变:T563A | A1CTG [(2Z,3aS,4R,6Z,7R,10aS)-10,10-dihydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methyl benzoate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD, STX-C13-OBz:Saxiphilin molar ratio 1.1:1
|
分辨率 2.45 Å R-free 0.263 |
| 9YBF Rana catesbeiana saxiphilin mutant - T563A:STX-C13-OBz (co-crystal) 提交 2025-09-17 | 突变/修饰不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
1–844(844 aa)
|
突变:T563A | A1CTG [(2Z,3aS,4R,6Z,7R,10aS)-10,10-dihydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl]methyl benzoate × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277.15 K;0.08-0.2 M sodium cacodylate, pH 6.5, 5% PEG8000, 33% MPD, STX-C13-OBz:Saxiphilin molar ratio 1.1:1
|
分辨率 2.45 Å R-free 0.263 |
共 14 个其他 PDB 条目、28 个 assembly。 打开独立比较页并筛选聚集状态
查看构建体与数据证据
| UniProt名称 | SAX_LITCT |
| Isoform | — |
| PDB实体 | 1 |
| 链与序列区间 | 作者链 A; PDB构建体 1–844; UniProt 1–844 作者链 B; PDB构建体 1–844; UniProt 1–844 |